Is Deccan Health Care a good stock to invest in?

Deccan Health Care can be analyzed on the following key metrics - TTM P/E: 29.72 Sector P/E: 45.09 Dividend Yield: 0% D/E ratio: -

Deccan Health Care Share Price

Sector: Biotechnology & Drugs

Powered by

20.30 +0.83 (4.26%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 19.48

Today’s High 20.89

52 Week Low 16.00

52 Week High 39.10

Key Metrics

Market Cap (In Cr) 47.48
Beta 1.18
Div. Yield (%) 0
P/B 0.45
TTM P/E 29.72
Sector P/E 45.09
D/E 0
Open Price 20.2
Prev Close 19.47

View All Metrics

Deccan Health Care Analysis

Price Analysis

1 Week

5.19%
3 Months

20.84%
6 Month

-31.56%
YTD

-30.68%
1 Year

-42.06%

Risk Meter

64% Low risk
64% Moderate risk
64% Balanced Risk
64% High risk
64% Extreme risk

Deccan Health Care News

Q4 results on May 27: LIC, Bosch, Info Edge, P&G Hygiene, Minda Corp, JK Lakshmi Cement, and Supriya Lifesciences are among 301 companies to release their earnings report today. (Representative Image)

Premium

Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more

2 min read . 27 May 2025

The Sensex closed at 52,372.69, down 13.50 points, while the Nifty was at 15,692.60, up 2.80 points on Monday. (File Photo: Reuters)

Premium

Stocks to Watch: RIL, Future Retail, PNB Housing Finance, Dr Reddy's

2 min read . 13 Jul 2021

View More News

Deccan Health Care Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
75.13

Selling/ General/ Admin Expenses Total
4.35

Depreciation/ Amortization
1.45

Other Operating Expenses Total
20.02

Total Operating Expense
73.39

Operating Income
1.74

Net Income Before Taxes
1.67

Net Income
1.2

Diluted Normalized EPS
0.47

Period
2024

Total Revenue
59.73

Selling/ General/ Admin Expenses Total
3.52

Depreciation/ Amortization
1.47

Other Operating Expenses Total
14.97

Total Operating Expense
57.44

Operating Income
2.28

Net Income Before Taxes
2.21

Net Income
1.49

Diluted Normalized EPS
0.8

Period
2023

Total Revenue
45.02

Selling/ General/ Admin Expenses Total
3.32

Depreciation/ Amortization
1.43

Other Operating Expenses Total
14.77

Total Operating Expense
44.49

Operating Income
0.53

Net Income Before Taxes
0.44

Net Income
0.31

Diluted Normalized EPS
0.24

Period
2022

Total Revenue
33.17

Selling/ General/ Admin Expenses Total
10.25

Depreciation/ Amortization
1.47

Other Operating Expenses Total
2.77

Total Operating Expense
32.7

Operating Income
0.47

Net Income Before Taxes
0.54

Net Income
0.32

Diluted Normalized EPS
1.49

Period
2021

Total Revenue
33.78

Selling/ General/ Admin Expenses Total
10.37

Depreciation/ Amortization
1.47

Other Operating Expenses Total
2.47

Total Operating Expense
33.2

Operating Income
0.57

Net Income Before Taxes
0.52

Net Income
0.39

Diluted Normalized EPS
0.25

Period
2020

Total Revenue
42.24

Selling/ General/ Admin Expenses Total
10.61

Depreciation/ Amortization
1.42

Other Operating Expenses Total
2.09

Total Operating Expense
31.99

Operating Income
10.26

Net Income Before Taxes
10.13

Net Income
10.09

Diluted Normalized EPS
6.42

Period
2019

Total Revenue
44.25

Selling/ General/ Admin Expenses Total
8.57

Depreciation/ Amortization
1.29

Other Operating Expenses Total
3.04

Total Operating Expense
28.73

Operating Income
15.52

Net Income Before Taxes
14.57

Net Income
14.48

Diluted Normalized EPS
10.29

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Deccan Health Care Technical

Moving Average SMA

5 Day19.16
10 Day19.84
20 Day20.78

50 Day20.04
100 Day20.88
300 Day24.65

Deccan Health Care Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Jeevan Scientific Technology
39.39
0.9
2.34
67.8
36.5
62.36

Lasa Supergenerics
10.29
0.49
5
33.49
8.52
51.55

Deccan Health Care
20.3
0.83
4.26
39.1
16
47.48

Crestchem
168.9
0.2
0.12
350
119.7
49.84

Sandu Pharmaceuticals
49.8
-0.41
-0.82
69.5
43.75
48.18

Deccan Health Care Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

16-Jun-25
Others

29-May-25
Audited Results

11-Apr-25
Allotment of Equity Shares & Others

01-Apr-25
Allotment of Equity Shares & Others

14-Feb-25
Quarterly Results

21-Dec-24
Allotment of Equity Shares & Others

14-Nov-24
Quarterly Results

21-Oct-24
Others

31-Jul-24
Quarterly Results

12-Jul-24
Others

Meeting Date
Announced on
Purpose

14-Apr-24
12-Mar-24
POM

30-Sept-23
29-Aug-23
POM

27-Sept-23
04-Sept-23
AGM

16-Mar-23
09-Feb-23
POM

06-Jun-22
05-May-22
POM

View All

Company Profile

ABOUT Deccan Health Care

Industry Biotechnology & Drugs
ISIN INE452W01019
BSE Code 542248

Deccan Health Care Limited is an India-based company, which is engaged in the business of manufacturing of nutraceuticals. The Company’s robust portfolio of 1500 market-ready products include 73 pioneering offerings and over 200 differentiated products. This includes several product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. Its key categories of nutraceuticals, including vitamins and minerals, probiotics, proteins and peptides, omega fatty acids and others. Its nutraceuticals are available in several forms, including capsules, tablets, soft gels, powders, liquids, and gummies. They find applications in functional foods, functional beverages, dietary supplements and personal care products.

MANAGEMENT

Minto Gupta Chairman of the Board, Compliance Officer, Managing Director
Parth Palera Chief Financial Officer
Meenakshi Gupta Additional Whole-Time Director
Mohak Gupta Additional Executive Director
Rani Umamaheswara Rao Whole Time Director

DECCAN HEALTH CARE SUMMARY

Deccan Health Care is trading 4.26% upper at Rs 20.30 as compared to its last closing price. Deccan Health Care has been trading in the price range of 20.89 & 19.48. Deccan Health Care has given -30.68% in this year & 5.19% in the last 5 days.

Deccan Health Care has TTM P/E ratio 29.72 as compared to the sector P/E of 45.09.

The company posted a net profit of 0.14 Crores in its last quarter.

Listed peers of Deccan Health Care include Jeevan Scientific Technology (2.34%), Lasa Supergenerics (5%), Deccan Health Care (4.26%) etc.

Deccan Health Care has a 19.46% promoter holding & 80.54% public holding.

FAQs about Deccan Health Care

Deccan Health Care is trading at 20.30 as on 27 Jun, 2025 3:28:04 PM. This is 4.26% upper as compared to its previous closing price of 19.47

The market capitalization of Deccan Health Care is 47.48 Cr as on 27 Jun, 2025 3:28:04 PM.

The 52 wk high for Deccan Health Care is 39.10 whereas the 52 wk low is 16.00

Deccan Health Care can be analyzed on the following key metrics -

TTM P/E: 29.72
Sector P/E: 45.09
Dividend Yield: 0%
D/E ratio: -

Deccan Health Care reported a net profit of 1.2 Cr in 2025.

Deccan Health Care Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Deccan Health Care Share Price

Price Range

Key Metrics

Deccan Health Care Analysis

Deccan Health Care News

Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more

Stocks to Watch: RIL, Future Retail, PNB Housing Finance, Dr Reddy's

Deccan Health Care Financials

Forecast

Forecast

Forecast

Deccan Health Care Technical

Deccan Health Care Peers

Deccan Health Care Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Deccan Health Care

MANAGEMENT

DECCAN HEALTH CARE SUMMARY

FAQs about Deccan Health Care

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue